Article Details
Retrieved on: 2021-09-30 19:18:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
MRNA – With more than 90% efficacy, BioNTech SE (BNTX) and Moderna, Inc's (MRNA) COVID-19 vaccines have gained the majority of market share and revenues ...
Article found on: stocknews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here